IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
Shu Wang,Jingya Wang,Varsha Kumar,Jodi L. Karnell,Brian Naiman,Phillip S. Gross,Saifur Rahman,Kamelia Zerrouki,Richard Hanna,Christopher Morehouse,Nicholas Holoweckyj,Hao Liu,Autoimmunity Molecular Medicine Team,Zerai Manna,Raphaela Goldbach-Mansky,Sarfaraz Hasni,Richard Siegel,Miguel Sanjuan,Katie Streicher,Michael P. Cancro,Roland Kolbeck,Rachel Ettinger,
DOI: https://doi.org/10.1038/s41467-018-03750-7
IF: 16.6
2018-05-01
Nature Communications
Abstract:Although the aetiology of systemic lupus erythematosus (SLE) is unclear, dysregulated B cell responses have been implicated. Here we show that an unusual CD11chiT-bet+ B cell subset, with a unique expression profile including chemokine receptors consistent with migration to target tissues, is expanded in SLE patients, present in nephrotic kidney, enriched for autoreactive specificities and correlates with defined clinical manifestations. IL-21 can potently induce CD11chiT-bet+ B cells and promote the differentiation of these cells into Ig-secreting autoreactive plasma cells. While murine studies have identified a role for T-bet-expressing B cells in autoimmunity, this study describes and exemplifies the importance of CD11chiT-bet+ B cells in human SLE.
multidisciplinary sciences